Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Open in API
Filings indexed 1,093 across all filing types
Latest filing 2013-02-20 Director's Dealing
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2013-02-20 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-02-12 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-02-12 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated February 11, 2013, announcing the appointment of a new independent director to the company's Board of Directors. The key section is Item 5.02, which specifically addresses the election of directors and appointment of officers. The document also includes a slide presentation and a press release as exhibits related to this appointment. There is no financial data or earnings information, nor is this an annual or quarterly report. The primary content is about a change in the company's board membership, which fits the category of Board/Management Information (MANG). The document length is 6301 characters, which is sufficient to contain detailed information about the director appointment. Therefore, the correct classification is MANG with high confidence.
2013-02-11 English
OWNERSHIP DOCUMENT
Director's Dealing
2013-02-01 English
SABBY 13G-A NBS 01.29.13
Major Shareholding Notification
2013-01-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.